Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology is now the right time?

Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology : is now the right time?

Copyright © 2013 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 150(2014), 1 vom: 01. Jan., Seite 51-63
1. Verfasser: Jethwa, Hannah (VerfasserIn)
Weitere Verfasser: Adami, Antonella A, Maher, John
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Review CAR CEA CNS Chimeric antigen receptor FoxP3 GITR Gene therapy mehr... GvHD Immunotherapy LTR MAGE MOG RRE Regulatory T-cell Rev response element T-cell receptor T1DM TGF-β carcinoembryonic antigen central nervous system chimeric antigen receptor glucocorticoid-induced TNFR-related protein graft versus host disease long terminal repeat melanoma-associated antigen myelin oligodendrocyte glycoprotein tTreg thymic regulatory T-cell transforming growth factor-β type 1 diabetes
Online verfügbar Volltext